Search

MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon and rectal cancer.

… Tuesday, March 21, 2017 Summary In this Q&A, MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon cancer and rectal cancer. Colorectal cancer is the third most common cancer in the United States for both men and women, excluding

Memorial Sloan Kettering Cancer Center (MSK) is the first academic research institution worldwide to join a major global initiative focused on revolutionizing clinical trial administration.

… Tuesday, December 17, 2024 Memorial Sloan Kettering Cancer Center (MSK) is the first academic research institution worldwide to join a major global initiative focused on revolutionizing clinical trial administration. The i-HD eSource Scale Up Task Force, led by the European Institute for Innovation through

Sloan Kettering Institute Structural Biology Program Chair Dr. Christopher Lima was elected to the 2025 class of American Association for the Advancement of Science Fellows.

… Tuesday, April 14, 2026 Christopher D. Lima, PhD , Chair of the Structural Biology Program at the Sloan Kettering Institute and a Howard Hughes Medical Institute Investigator was named a 2025 Honorary Fellow of the  American Association for the Advancement of Science  — one of the world’s largest scientific

Uterine-preserving surgery results in excellent and similar five-year disease-specific survival compared to hysterectomy in young women with stage IB1 cervical cancer.

… Monday, January 14, 2019 Uterine-preserving surgery results in excellent and similar five-year disease-specific survival compared to hysterectomy in young women with stage IB1 cervical cancer , especially in women with smaller tumors, according to our recent research. The retrospective study is one of

Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite Covid-19 according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S. academic institutions.

… Monday, May 11, 2020 Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite the challenges of Covid-19, according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S.

Our review summarizes recent developments in treatment planning and delivery, existing clinical evidence, and ongoing prospective trials in major head and neck cancers that may further increase the therapeutic window of proton therapy for patients with head and neck cancer.

… Tuesday, October 13, 2020 Proton beam radiation has distinct tissue-sparing advantages over conventional photon-based radiation, making it especially beneficial for treating localized head and neck cancers, which typically have complex anatomy and are located near vital organs. We recently published

… Thursday, March 9, 2023 Update:  On November 27, 2023, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at Memorial Sloan Kettering Cancer Center. Nirogacestat

Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer.

… Monday, July 31, 2017 Summary Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer. Dr. Kris co-chaired a panel that is releasing the guidelines. The American Society of Clinical Oncology (ASCO

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.

… Monday, November 4, 2013 Summary Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research. Watch the video, Cancer Research Advances and Trends, on YouTube. Few high school students get the opportunity to learn about cutting-edge science

philanthropist and art collector Iris Cantor has made a major commitment to Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers.

… Wednesday, April 18, 2007 Philanthropist and art collector Iris Cantor has made a major commitment to New York’s Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers. Mrs. Cantor is establishing the position with support totaling